Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Thalitero 50 mg Capsule
Manufacturer/Marketed By : Hetero Healthcare Ltd
$5.10 $3.98
Thalitero 50 mg capsules are a vital medication for managing multiple myeloma, a type of cancer that affects plasma cells in the blood. This medication can be utilized alone or...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Thalidomide 50 mg
Active Pharmaceutical Ingredient
Thalitero 50 mg Capsule
5,10 $US
3,98 $US
Thalitero 50 mg capsules are a vital medication for managing multiple myeloma, a type of cancer that affects plasma cells in the blood. This medication can be utilized alone or in combination with other therapies to enhance treatment efficacy. Additionally, Thalitero plays a significant role in treating and preventing the symptoms associated with erythema nodosum leprosum (ENL), a painful skin condition linked to leprosy, while also serving as a maintenance therapy to reduce the likelihood of ENL recurrence. It is crucial to note that Thalitero is not suitable for children under the age of 12, so healthcare providers should carefully evaluate its use in younger patients. By targeting the underlying mechanisms of these conditions, Thalitero helps improve patients' quality of life. As with any medication, patients should be aware of potential side effects and discuss any concerns with their healthcare professional. Overall, Thalitero 50 mg capsules represent a significant advancement in the treatment landscape for multiple myeloma and ENL management.
Active Pharmaceutical Ingredient
Uses
• Thalitero 50 mg capsule is primarily used to manage specific conditions related to blood flow and circulation. It works by improving blood vessel function, which can help alleviate symptoms associated with poor circulation. Patients may find relief from discomfort and experience improved mobility. This makes Thalitero 50 mg capsule a valuable option for those facing circulation challenges.
• In addition to enhancing circulation, Thalitero 50 mg capsule may be prescribed to support certain cardiovascular health goals. It aids in promoting overall heart function, which is essential for maintaining a healthy lifestyle. Regular use of Thalitero 50 mg capsule can contribute to better heart health over time. This makes it an important part of a comprehensive treatment plan for individuals with specific cardiovascular needs.
• Thalitero 50 mg capsule can also be beneficial for patients undergoing specific therapies that require enhanced vascular health. For example, those receiving treatments that affect blood flow may find this medication supportive in maintaining optimal circulation. By incorporating Thalitero 50 mg capsule into their regimen, patients can potentially improve their treatment outcomes. This highlights the capsule's role in facilitating better health during therapeutic interventions.
• Furthermore, Thalitero 50 mg capsule may assist in improving exercise tolerance for individuals with certain conditions. By promoting better blood flow, it can help enhance endurance and reduce fatigue during physical activities. Patients may notice an increase in their ability to engage in daily exercises or rehabilitation programs. Thus, Thalitero 50 mg capsule serves as a helpful ally in achieving fitness and activity goals.
Benefits
Multiple myeloma: Multiple myeloma is a cancer that affects plasma cells, a type of white blood cell found in the bone marrow. Plasma cells are responsible for making antibodies that help the body fight infections. In multiple myeloma, abnormal plasma cells accumulate in the bone marrow, crowding out normal cells and leading to the production of abnormal antibodies. Thalitero 50 mg Capsule has immunomodulatory and anti-angiogenic properties. It is thought to exert its anti-myeloma effects by modulating the immune system and inhibiting the growth of blood vessels that support the tumour. Erythema nodosum leprosum (ENL): Erythema nodosum leprosum (ENL) is a type of reaction associated with leprosy, a chronic infectious disease caused by the bacterium Mycobacterium leprae. Erythema nodosum leprosum is characterised by the sudden onset of painful, erythematous (reddish) and nodular skin lesions. Thalitero 50 mg has been shown to be very effective in the treatment of ENL. It helps to relieve symptoms, reduce inflammation and improve the overall quality of life of people affected by this condition.
Side Effects
As with all medicines, Thalitero 50 mg Capsule may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Drowsiness
• Swelling
• Anxiety
• Nausea
• Vomiting
• Body Pain
• Nausea
• Fatigue
• Weight gain or loss.
• Low blood pressure
Common Side Effects
• Low white blood cell count
• Increased bilirubin
• Blood clotting
• Joint pain
• Muscle pain
• Slow heat rate
• Low or high blood pressure
• Severe nerve damage
• Muscle cramps
How To Use
Thalitero Capsule can be taken at the same time each day, one hour after a meal. The appropriate dose and frequency of this medicine will be determined by your doctor based on your specific condition, and these instructions may be adjusted as necessary. The effectiveness of this medicine is dependent on it.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Thalitero 50 mg. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you consumption of alcohol is safe or not.
• Kidney: Thalitero 50 mg Capsule is likely to be safe for use in patients with kidney disease. The limited data available suggest that it may not be necessary to adjust the dose of Thalitero Capsule in these patients. Consult your doctor for advice.
• Breastfeeding: Breastfeeding while taking Thalitero Capsule is not recommended. It can pass into breast milk and may cause harm to the baby. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed if you are breastfeeding and taking this medicine. Your doctor can help you make the best decision for you and your baby's health.
• Liver: Thalitero 50 mg Capsule is likely to be safe for use in patients with liver disease. The limited data available suggest that it may not be necessary to adjust the dose of Thalitero Capsule in these patients. Consult your doctor for advice.
• Pregnancy: Use of Thalitero 50 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Thalitero Capsule during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Thalitero 50 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Thalitero 50.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.